| BXP |
Report |
FFO per diluted share |
IN-LINE |
pred ~$1.71 vs. cons $1.71 |
MEDIUM |
| BXP |
Report |
Total portfolio occupancy |
BEAT |
pred ~88.1% vs. cons 87.2% |
MEDIUM |
| BXP |
Report |
Total revenue |
BEAT |
pred ~$858M vs. cons $844M |
LOW |
| BXP |
Guide |
Q3 2026 FFO per diluted share guidance |
LOWER |
guide ~$1.71 vs. cons $1.74 (Q3 2026) |
MEDIUM |
| BXP |
Guide |
FY 2026 FFO per diluted share guidance |
LOWER |
guide ~$6.96 midpoint vs. cons $7.01 (FY 2026) |
HIGH |
| BXP |
Guide |
FY 2026 same-property NOI growth guidance ex. termination income |
UNCHANGED |
guide ~1.9% midpoint vs. cons 1.9% (FY 2026) |
MEDIUM |
| BXP |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| BXP |
Return |
5-day cumulative residual |
-2.5% (FOLLOW-THROUGH) |
A ~$1.71 Q2 FFO result versus $1.71 consensus is unlikely to offset a FY26 FFO midpoint of ~$6.96 versus $7.01 consensus; the ~$0.05 out-period shortfall implies downward estimate revisions despite occupancy of ~88.1% versus 87.2%. |
MEDIUM |